Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32652742.
- Also identified by DOI 10.1002/hed.26359.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although many studies focus on short-term side effects of radioiodine therapy, almost none studied long-term side effects. We assessed radioiodine long-term salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma and compared it to short-term morbidity within the same population. A standardized self-administrated questionnaire was submitted in 2019 by patients treated with radioiodine between January 2011 and December 2012. These patients had already answered the same questionnaire 6 years before. Our study showed a significant reduction for salivary side effects: discomfort in submandibular or parotid area, swelling, pain, a bad or salty taste in the mouth, allowing to get back to a "normal" diet. Our study suggests that a significant rate of patients will recover from I<sup>131</sup> therapy salivary side effects. As almost 30% of these remissions happened during our late stage follow-up, we highlight the necessity of a long-term follow-up in these patients.
Medical subject headings
- Thyroid Neoplasms
- Xerostomia